BRIEF published on 06/27/2024 at 07:05, 2 years 3 months ago SCHOTT Pharma Reports Robust Growth in Q2 of Fiscal Year 2024 Global Expansion Revenue Growth SCHOTT Pharma Q2 2024 High-value Solutions
BRIEF published on 06/27/2024 at 07:05, 2 years 3 months ago SCHOTT Pharma annonce une croissance robuste au deuxième trimestre de l'exercice 2024 SCHOTT Pharma Expansion Mondiale Solutions À Haute Valeur Ajoutée Hausse Des Revenus T2 2024
PRESS RELEASE published on 06/27/2024 at 07:00, 2 years 3 months ago SCHOTT Pharma continues growth path in the second quarter of fiscal year 2024 SCHOTT Pharma reports 11% revenue growth in Q2 2024, reaffirms guidance for fiscal year. Focus on high-value solutions and expansion. Key figures and strategic developments outlined Financial Results Expansion Revenue Growth SCHOTT Pharma High-value Solutions
BRIEF published on 06/14/2024 at 13:03, 2 years 4 months ago SCHOTT Pharma Opens State-of-the-Art Production Facility in Hungary SCHOTT Pharma Pharmaceutical Trends Hungary Production Facility Glass Syringes
BRIEF published on 06/14/2024 at 13:03, 2 years 4 months ago SCHOTT Pharma ouvre une usine de production de pointe en Hongrie SCHOTT Pharma Usine Hongrie Seringues En Verre Tendances Pharmaceutiques
PRESS RELEASE published on 06/14/2024 at 12:58, 2 years 4 months ago Expanding prefillable glass syringe output: SCHOTT Pharma opens state-of-the-art production facility in Lukácsháza, Hungary SCHOTT Pharma opens new production facility in Hungary, expanding prefillable glass syringe output to support pharma market growth and trends SCHOTT Pharma Pharma Industry Hungary Production Facility Prefillable Glass Syringes
BRIEF published on 05/14/2024 at 18:24, 2 years 5 months ago SCHOTT Pharma Reaffirms FY 24 Outlook, Anticipates Slower Growth in FY 25 Due to Reduced Syringe Demand Financial Results SCHOTT Pharma FY 24 Forecast FY 25 Growth Impact Syringe Demand Decrease
BRIEF published on 05/14/2024 at 18:24, 2 years 5 months ago SCHOTT Pharma réaffirme ses perspectives pour l’exercice 24 et prévoit un ralentissement de la croissance au cours de l’exercice 25 en raison de la réduction de la demande de seringues Résultats Financiers SCHOTT Pharma Prévisions Pour L'exercice 24 Impact Sur La Croissance Pour L’exercice 25 Diminution De La Demande En Seringues
PRESS RELEASE published on 05/14/2024 at 18:19, 2 years 5 months ago SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from syringes SCHOTT Pharma confirms FY 24 outlook based on Q2 results; FY 25 impacted by slower growth from syringes. H1 24 revenues up 9% at constant currencies Revenue Growth SCHOTT Pharma Syringes FY 24 FY 25
BRIEF published on 05/14/2024 at 18:08, 2 years 5 months ago SCHOTT Pharma Anticipates Fiscal Year 2025 Impact Due to Slower Syringe Sales Revenue Growth EBITDA Margin SCHOTT Pharma Fiscal Year 2025 Syringe Demand
Published on 10/15/2026 at 13:05, 18 minutes ago Impauer Technologies Announces Commercial Launch of Pauerone Wallet V1 Across Android, Web, And Browser Extension
Published on 10/15/2026 at 13:00, 23 minutes ago BULGOLD Defines the 2.2km-Long BL Vein Corridor at the Lutila Gold Project
Published on 10/15/2026 at 13:00, 23 minutes ago Nepra Foods Appoints Kim Mayo Chief Operating Officer
Published on 10/15/2026 at 13:00, 23 minutes ago CoTec and Battery Mineral Resources Enter Strategic Partnership to Unlock Additional Copper Production and Growth Opportunities at Punitaqui
Published on 10/15/2026 at 13:05, 17 minutes ago The Next Evolution of ASKB: Your Insights, Bloomberg's Intelligence, One Conversation
Published on 10/15/2026 at 12:47, 35 minutes ago Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program XS3202009547
Published on 10/15/2026 at 12:43, 39 minutes ago Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program XS3195123065
Published on 10/15/2026 at 12:40, 42 minutes ago Turkiye Garanti Bankasi A.S.: Board of Directors Resolution Regarding the Issuance of Asset-Backed Securities
Published on 10/15/2026 at 12:37, 45 minutes ago Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program XS3200020363
Published on 10/15/2026 at 07:27, 5 hours 55 minutes ago Saint-Gobain strengthens its infrastructure offer in North America with the acquisition of D.S. Brown in construction chemicals
Published on 10/15/2026 at 07:27, 5 hours 55 minutes ago Saint-Gobain renforce son offre pour le marché des infrastructures en Amérique du Nord avec l’acquisition de D.S. Brown dans la chimie de la construction
Published on 10/14/2026 at 18:00, 19 hours 23 minutes ago CIS : Chiffre d’affaires du 3ème trimestre 2026 supérieur aux attentes : accélération de la croissance et visibilité renforcée.
Published on 10/14/2026 at 18:00, 19 hours 23 minutes ago CIS : Q3 2026 revenue higher than expected: accelerated growth and increased visibility.
